MMJ Recs

DECEMBER 20, 2023

The establishment of medical marijuana dispensaries in Virginia represents a progressive approach to healthcare, offering patients alternative treatment options for various medical conditions. Patients diagnosed with specific medical conditions are eligible to participate in the state’s medical cannabis program.

Dispensary 52

Dispensary Marijuana Strains Patients 52

Cannabis Law Report

JUNE 1, 2021

The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

The Joint Blog

APRIL 17, 2020

But as an older user-base with more complicated medical conditions continue to grow, it is important to understand how THC could adversely impact other co-administered medications. Medical cannabis is typically prescribed for patients with severe conditions including inflammatory conditions (e.g.,

Events 48

Events THC Chronic Pain Sleep 48

Cannabis Law Report

AUGUST 27, 2021

The Board will advise Delic and its subsidiaries, including Ketamine Infusion Centers, Delic Labs and others, as they develop safety protocols and best practices pertaining to legal psychedelic wellness treatments today and those legalized in the future. About Delic Corp, Inc.

Research and Development 98

Research and Development Treatment Media Medicine 98

Cannabis Law Report

MAY 24, 2022

The issue in this case is whether an employer, under the workers compensation laws of New York, is required to reimburse a patient for medical marijuana, which was prescribed as a form of pain treatment? 1] [2] The Workers’ Compensation Law also requires that treatment be rendered in accordance with its Medical Treatment Guidelines.

Chronic Pain 52

Chronic Pain Marijuana Treatment Therapy 52

MMJ Recs

DECEMBER 15, 2023

However, the scientific evidence supporting its efficacy for insomnia treatment is still limited, and the long-term effects and potential risks should be carefully considered. There are two main types of insomnia: acute and chronic. Daytime fatigue, difficulty concentrating, and irritability are common consequences of chronic insomnia.

Strains 98

Strains Sleep THC Chronic Pain 98

Veriheal

JULY 12, 2021

According to the American Psychiatric Association , PTSD is a “psychiatric disorder that may occur in people who have experienced or witnessed a traumatic event such as natural disaster, as a serious accident, a terrorist act, war/combat or rape or who have been threatened with death, sexual violence or serious injury”.

Treatment 104

Treatment Sleep Clinical Trials Data 104

Veriheal

FEBRUARY 28, 2021

It helps to showcase the 103 countries holding events on this day as well as the thousands of events hosted online worldwide. This year, COVID-19 has dramatically impacted the way events are hosted. Instead of having physical locations, many events have opted to go digital being held online.

Chronic Pain 52

Chronic Pain Events Therapy Treatment 52

Cannabis Law Report

JANUARY 12, 2022

“This is a landmark event for Gb Sciences,” said Chairman and CEO John Poss. and three international patents that have been issued to protect therapeutic mixtures for Parkinson’s disease, chronic pain, hyperinflammation, and heart disease. .” In addition, Gb Sciences has 12 U.S.

Research and Development 52

Research and Development Clinical Trials Chronic Pain Therapy 52

Cannabis Law Report

JUNE 23, 2021

Across all patients, findings are reported in health-related quality of life as well as within specific conditions such as pain, anxiety, and palliative care. Patient Laura Drummond is prescribed medical cannabis for a persistent pain condition fibromyalgia. Improved quality of life.

Cannabinoids 59

Cannabinoids Data Chronic Pain Sleep 59

MMJ Recs

APRIL 9, 2024

From alleviating chronic pain to reducing inflammation, cannabis offers a range of benefits that can enhance physical and mental health. Moreover, medical marijuana has shown promise in addressing mental health concerns, offering a natural alternative for conditions like anxiety, depression, and PTSD.

Marijuana 52

Marijuana Strains Chronic Pain THC 52

Cannabis Law Report

NOVEMBER 26, 2019

In Canada today, close to 70% of all those surveyed aged 19+ believe that cannabis is an alternate form of treatment to some medical conditions according to Vividata’s Vivintel , the nation’s largest syndicated cannabis consumer study. We are partnering with Canopy Growth to offer a unique event of fun and canna-learning.

Chronic Pain 91

Chronic Pain Events THC Education 91

Cannabis Law Report

JUNE 8, 2021

Inflammation has specifically been implicated in the pathophysiology of Parkinson’s Disease, chronic pain, and bipolar disorder. A better understanding of the anti-inflammatory effects of psilocybin has potential to allow for optimization and personalization of psilocybin treatment.”. About Silo Pharma. Silo Pharma. Brett Maas.

Patients 92

Patients Research and Development Clinical Trials Chronic Pain 92

Veriheal

JANUARY 20, 2021

PTSD can have far-reaching effects on health, functionality as well as on quality of living, which is why having access to effective treatment is so important. Post-traumatic stress disorder (PTSD) is a mental condition that is developed following a traumatic event and can cause difficulty in adjusting to and coping with life after the event.

Strains 57

Strains Terpenes Chronic Pain Cannabinoids 57

MMJ Recs

APRIL 30, 2022

The first thing you’ll need to do is find out if you qualify for medical marijuana by checking which qualifying conditions are listed and determining whether you fall into any of the categories. The certification process is same-day, meaning each patient can gain access to MMJ treatment the day of their appointment through the patient drive.

Patients 52

Patients Dispensary Chronic Pain Access 52

MMJ Recs

OCTOBER 2, 2023

California has been a trailblazer in the realm of medical marijuana, offering patients access to a variety of treatment options. Patients must first schedule an appointment with a licensed medical professional who can evaluate their medical history and condition.

Dispensary 52

Dispensary Patients Environment Conditions 52

MMJ Recs

MARCH 25, 2022

MMJ is proven to help with numerous medical conditions. It offers pain relief and peace of mind for those with a qualifying condition. There may be other qualifying conditions for a NY MMJ card. Your doctor will certify your application if they are assured that MMJ will help your medical condition.

Patients 52

Patients Conditions Chronic Pain Dispensary 52

MMJ Recs

MARCH 2, 2024

Observing discretion in discussions regarding medical conditions and treatment enhances privacy and respect among patrons. A: To get a medical marijuana card in Ohio, you must be diagnosed with a qualifying medical condition by a certified physician and then register with the Ohio Medical Marijuana Control Program.

Dispensary 52

Dispensary Patients Marijuana Education 52

Cannabis Law Report

NOVEMBER 9, 2021

(“Delic” or the “Company”) (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) (Original Source), a leader in new medicines and treatments for a modern world, today announced the official, completed acquisition of Ketamine Wellness Centers Arizona LLC (“KWC”), becoming the largest chain of wellness centers providing ketamine treatments in the U.S.

Treatment 52

Treatment Therapy Media Access 52

PrestoDoctor

JUNE 2, 2020

Even in this event, you might still want to see a medical marijuana doctor. During the meeting, you can state to the doctor why you want a medical marijuana card, and what existing conditions you have. From these factors, they will ascertain whether or not medical marijuana would be a good treatment option. Where to Go.

Marijuana 52

Marijuana Epilepsy Conditions Chronic Pain 52

Kind Meds (Cannabis Education Blog)

AUGUST 16, 2021

It doesn’t give a huge boost to one’s muscles like steroids or allow your blood to carry more oxygen like PEO, and an epileptic who treats their seizures with a cannabinoid tincture is only made less susceptible to seizures during events and training. These risks (and benefits) aren’t unknown to the players either. The Big CTE.

Marijuana 111

Marijuana Chronic Pain Tincture Cannabinoids 111

Otherside Farms

JANUARY 17, 2020

CBD is therefore convenient to those that suffer nausea from chemotherapy treatment and other conditions. People who are suffering from different conditions might lose appetite, which prevents them from eating well. CBD can help in alleviating those conditions that prevent them from feeling hungry. Controlling hunger.

Food 52

Food Research and Development Seed-To-Sale Vaping 52

SpeedWeed

AUGUST 4, 2021

After watching my brother self-medicate for his chronic pain for decades, I didn’t understand how cannabis was important to him as a medicine. I always thought he used his chronic pain as an “excuse” to self-administer what I thought was a toxic drug. . What motivated you to enter the industry?

Chronic Pain 52

Chronic Pain Research and Development Medicine Supply Chain 52

Healer

DECEMBER 17, 2021

Drug interactions reported in the scientific literature most often occur at very high doses used in clinical trials of epilepsy and other conditions. For example, most statin drugs can cause memory issues, muscle pain, fatigue and muscle weakness. No case reports of this interaction have been described in the scientific literature.

CBD 98

CBD THC Conditions Medicine 98

The Joint Blog

JUNE 28, 2019

According to new research, the use of marijuana is a safe and effective treatment for those with fibromyalgia. It was found that 81% of participants reported “at least moderate improvement in their condition”, and this occurred “without experiencing serious adverse events. National Institute of Health.

Therapy 44

Therapy Chronic Pain Treatment Marijuana 44

Cannabis Law Report

NOVEMBER 26, 2021

In the event that manufacturing costs from Canada become materially higher than the cost to produce in Colombia, FloVaria will explore moving its supply chain activities of Avaria products to Flora Lab. KaLaya Observational Study on Pain Relief. felt pain relief within one minute. About Flora Growth’s Recent Financing.

Wellness and Beauty 52

Wellness and Beauty Supply Chain Research and Development Events 52

CannaEffect

OCTOBER 31, 2017

After nearly 20 years of crippling pain and bizarre medical treatments, Heather can walk her three dogs in the sunshine and smile thanks to Real Scientific Hemp Oil, CBD oil by HempMeds. Although she has lived with chronic pain since she was 15, Heather’s determined to make a difference. “I

Oil 79

Oil CBD Chronic Pain Treatment 79

Cannabis Law Report

AUGUST 24, 2021

. “Nearly 100,000 people in the United States have idiopathic pulmonary fibrosis (IPF), and although cases continue to climb, there is still a significant unmet need in treatment options for this chronic disease,” said Chris Chapman, M.D., President, Director and Chief Medical Officer. Investor Contact: Robert Schatz.

Pharmaceutical 98

Pharmaceutical Clinical Trials Chronic Pain CBD 98

CannaMD

JUNE 6, 2020

While this is great, one caveat to this was that with chronic pain patients specifically, tolerance to marijuana’s sleep benefits was noted. THC cannabis three times a day, over the course of 5 days, neuropathic pain patients experienced reduced pain intensity and better sleep. Find Out if You Qualify. Get Started.

Sleep 82

Sleep Marijuana Indica Chronic Pain 82

Cannabis Law Report

DECEMBER 1, 2021

Because it can cross the blood-brain barrier and gain access to the central nervous system (CNS), MYMD-1 is also positioned to be a possible treatment for brain-related disorders. The Company believes that Supera-CBD is currently on a path toward human clinical trials as a therapy for epilepsy, followed by chronic pain.

Pharmaceutical 52

Pharmaceutical Clinical Trials Chronic Pain Therapy 52

Cannabis Law Report

OCTOBER 6, 2021

Flora Pharma’s objective is to create and leverage a proprietary drug development platform in collaboration with an artificial intelligence and machine learning group to identify new bioactive compounds within the cannabis plant that interact with certain gene targets responsible for specific disease states and conditions.

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical Events 52

Cannabis Law Report

OCTOBER 19, 2021

MYMD-1’s primary purpose is to slow the aging process and extend healthy lifespan, and it is also showing promise as a potential treatment for post- COVID-19 complications and as an anti-fibrotic and anti-prolific therapeutic. The Company’s second drug platform, Supera-CBD , is being developed to treat chronic pain, addiction and epilepsy.

Pharmaceutical 52

Pharmaceutical Therapy Clinical Trials Chronic Pain 52

TheAnswerPage

JANUARY 11, 2022

As reviewed in a recent Forbes article, “a study of more than 400 health care professionals has revealed that most physicians lack knowledge of medicinal cannabis, with 65% saying that they have been asked about medical marijuana as a treatment for chronic pain but were unable to answer their patients’ questions” (1).

Patients 98

Patients Education Marijuana Therapy 98

Veriheal

MAY 3, 2022

The importance of the research is based on the fact that there is no “strong clinical literature” to support the widespread use of cannabis products for a variety of conditions, and that the effects of owning an MMJ card are “largely unknown.” The researchers split their participants into two groups with a ratio of 2:1.

Research and Development 95

Research and Development Clinical Trials Consumption Patients 95

Healer

DECEMBER 17, 2021

Drug interactions reported in the scientific literature most often occur at very high doses used in clinical trials of epilepsy and other conditions.[1]. For example, most statin drugs can cause memory issues, muscle pain, fatigue and muscle weakness. No case reports of this interaction have been described in the scientific literature.

CBD 52

CBD THC Conditions Medicine 52

Cannabis Law Report

NOVEMBER 23, 2021

It’s also important to note that MYMD-1 shows promise in pre-clinical studies as a treatment for immune diseases including rheumatoid arthritis, multiple sclerosis, and Hashimoto’s thyroiditis, and as an anti-fibrotic and anti-proliferation therapeutic.”. MyMD Contact: Robert Schatz. 646) 421-9523. rschatz@mymd.com www.mymd.com.

Pharmaceutical 52

Pharmaceutical Clinical Trials Therapy Chronic Pain 52

Cannabis Law Report

JANUARY 5, 2022

The issued claims protect the use of MYMD-1 in a method of treatment for the progressive and generalized loss of skeletal muscle mass and strength known as sarcopenia. MYMD-1 also shows promise in pre-clinical studies as a potential treatment for post- COVID-19 complications and as an anti-fibrotic and anti-proliferation therapeutic.

Pharmaceutical 52

Pharmaceutical Clinical Trials Therapy Treatment 52